| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/31/2008 | US20080182851 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 07/31/2008 | US20080182838 (5-{5-[4-(2-Bromo-5-fluorophenoxy)piperidin-1-yl]pyrazin-2-yl}-2H-tetrazol-2-yl)acetic acid; metabolic disorders,antidiabetic, hypoglycemic agent; obesity, insulin resistance, liver steatosis, atherosclerosis, neurological disease, dyslipidemia, hyperlipidemia, low HDL, and high LDL |
| 07/31/2008 | US20080182832 orphan nuclear Receptor agonists; chenodeoxycholic acid, ursodeoxycholic acid or cholic acid derivatives; atherosclerosis, arteriosclerosis, dyslipidemia, hypercholesterolemia, and hypertriglyceridemia.atherosclerosis, arteriosclerosis, hypercholestremia, and hyperlipidemia |
| 07/31/2008 | US20080182824 e.g. N-methyl-N-propargyl-4-hydroxybenzyl amine; monoamine oxidase inhibitors; are mediated via a peripheral (i.e., non-CNS) mechanism; antidiabetic agent, metabolic disordes, obesity, insulin resistance |
| 07/31/2008 | US20080182802 Spiroheterocyclic glycosides and mehtods of use |
| 07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
| 07/31/2008 | US20080182797 Short peptides comprising the amino acid sequence Cys-Glu-Phe-His as well as analogs and derivatives thereof, which peptides efficiently denitrate cellular proteins and thus prevent tissue damage associated with excess nitric oxide and its reactive species; protection against ischemia/reperfusion injury |
| 07/31/2008 | US20080182787 Protein isolated from plants (Moringa) or synthesized by recombinant DNA technology; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 07/31/2008 | US20080182786 Target protein is supported on carrier made from a clay mineral, and by adding this to cells it is possible to introduce the target protein into the cells; clay mineral is preferably a layered clay mineral such as montmorillonite, vermiculite, and illite |
| 07/31/2008 | US20080182785 Protracted Glp-1 Compounds |
| 07/31/2008 | US20080182313 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 07/31/2008 | US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy |
| 07/31/2008 | US20080181972 alpha -lipoic acid, ascorbic acid, and alpha -tocopherol, optionally one or more other antioxidants, beneficial minerals, and/or nutritional or dietary materials; diabetic retinopathy or diabetic macular edema, cataract, glaucoma, ocular inflammation |
| 07/31/2008 | US20080181970 vanadyl sulfate and dipeptidyl peptidase IV inhibitor (LAF237, MK0431, PSN9301, SYR619, SYR322, LAF237); synergistically reduce the glycoslated hemoglobin HbA1c levels |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181940 Method For Accelerating Expression of CPT-1 |
| 07/31/2008 | US20080181877 bioassay of forskolin or phorbol 12-myristate 13-acetate; increase sensitivity of the protein kinase A signalling pathway, increase insulin sensitivity, thermogenesis; obesity, type 2 diabetes, insulin resistance, hypertriglyceridemia, cancer, increase plasma levels of free fatty acids |
| 07/31/2008 | US20080181872 adeno-associated virus vector biodrug for Parkinson's disease, Huntington's disease, Alzheimer's disease, Down syndrome, rheumatoid arthritis, Crohn's disease; gene therapy of amyotrophic lateral sclerosis; drug creening; sustained release for prevent oxidative damage from superoxide buildup |
| 07/31/2008 | CA2676199A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/31/2008 | CA2676051A1 Insulin sensitisers and methods of treatment |
| 07/31/2008 | CA2675142A1 Fused aromatic difluoromethanephosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 07/31/2008 | CA2673164A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 07/30/2008 | EP1950301A2 Antibody for use in Therapy |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950203A1 Substituted pyrazoline compounds with ACAT, their preparation and use as medicaments |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1949908A1 Combined use of derivatives of GLP-1 analogs and PPAR ligands |
| 07/30/2008 | EP1949792A2 The healthy and functional foods for the obesity patients using purple-colored potato |
| 07/30/2008 | EP1948656A2 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948652A1 Glucokinase activators |
| 07/30/2008 | EP1948645A1 Tricyclo substituted amides |
| 07/30/2008 | EP1948636A2 Compounds and compositions as lxr modulators |
| 07/30/2008 | EP1948623A2 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/30/2008 | EP1948622A1 Tricyclo substituted amides as glucokinase modulators |
| 07/30/2008 | EP1948618A1 Crystalline rosuvastatin calcium |
| 07/30/2008 | EP1948604A1 Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948602A2 Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948190A2 Pharmaceutical use of substituted amides |
| 07/30/2008 | EP1948163A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 07/30/2008 | EP1948158A1 Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 07/30/2008 | EP1948152A2 Compounds for the treatment of metabolic disorders |
| 07/30/2008 | EP1948150A2 Combinations of metformin and meglitinide |
| 07/30/2008 | EP1948149A2 Formulation comprising metformin and vildagliptin |
| 07/30/2008 | EP1948144A2 Diaryl urea for treating diabetic neuropathy |
| 07/30/2008 | EP1685113B1 Substituted pyrazoles as ppar agonists |
| 07/30/2008 | EP1658069B1 Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1401259B1 Delta-4 desaturase genes and uses thereof |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1328269B2 Association of a cb1 receptor antagonist and sibutramin for treating obesity |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | EP1059927B1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 07/30/2008 | EP1054881B1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/30/2008 | CN101233231A Anti-obesity agent and anti-obesity food |
| 07/30/2008 | CN101233145A Agent for amelioration of insulin resistance |
| 07/30/2008 | CN101233133A Hydrochlorides and hydrates of 1-[(3-cyanopyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)xanthine, their preparation and their use as medicaments |
| 07/30/2008 | CN101233128A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 07/30/2008 | CN101233114A New imidazole carboxamides, useful to treat e.g. pathologies associated with the insulin resistance syndrome, are fructose-1,6-biphosphatase inhibitors |
| 07/30/2008 | CN101232899A Method of preserving the function of insulin-producing cells |
| 07/30/2008 | CN101232886A Methods of using potassium channel inhibiting compounds |
| 07/30/2008 | CN101232883A Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 07/30/2008 | CN101230102A Neutralizing antibodies against GDF-8 and uses therefor |
| 07/30/2008 | CN101230059A Bicycle aza alkyl derivative, preparation method and use in medicine thereof |
| 07/30/2008 | CN101230058A Bicycle aza alkyl derivative, preparation method and use in medicine thereof |
| 07/30/2008 | CN101230055A Lovastatin analogue as well as preparation method and uses thereof |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN101229373A Medicine compounds for treating diabetic nephropathy |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229368A Method of using proteinase to diabetic foot gangrene |
| 07/30/2008 | CN101229316A Rhizoma anemarrhenae extrac and applications as type 2 diabetes-curing medicine thereof |
| 07/30/2008 | CN101229312A Medicine compounds capable of regulating hypertension, hyperlipemia and angina |
| 07/30/2008 | CN101229305A Process for fabricating Sanhe sugar capsule |
| 07/30/2008 | CN101229296A Medicine compounds for treating hypertension, heart disease and angina |
| 07/30/2008 | CN101229279A Collateral-dredging antihyperlipidemic product containing dark tea active substance and preparing method thereof |
| 07/30/2008 | CN101229274A Pharmaceutical composition for preventing or treating impotence induced hyperlipidemia and/or hypertension |
| 07/30/2008 | CN101229273A Medlar multi-vitamins calcium tablet |
| 07/30/2008 | CN101229270A Blood-sugar reducing Chinese traditional medicine preparation capsule capable of preventing diabetes |
| 07/30/2008 | CN101229269A Blood-sugar reducing Chinese traditional medicine preparation capsule for treating diabetes |
| 07/30/2008 | CN101229265A Antidiabetics and antiatheroscloresis medicine compounds and preparing method thereof |
| 07/30/2008 | CN101229264A Chinese traditional medicine prescription and preparation of active ingredient thereof |
| 07/30/2008 | CN101229233A Chinese traditional medicine preparation for antiatheroscloresis and liver-protection, and preparingng method thereof |
| 07/30/2008 | CN101229226A Novel technology of extracting salvianic acid from salvia miltiorrhiza |
| 07/30/2008 | CN101229218A Vanadium compounds for curing diabetes and preparing method thereof |
| 07/30/2008 | CN101229181A Medicine compounds for curing diabetes and complications thereof |
| 07/30/2008 | CN101228957A Method of preparing low molecular active substance pill of holothurian and oyster |
| 07/30/2008 | CN101228943A Konjak bean vermicelli and producing method thereof |
| 07/30/2008 | CN101228936A Low calorific value bean paste and preparing method thereof |
| 07/30/2008 | CN101228935A Weight-losing and antidiabetic instant rice |
| 07/30/2008 | CN101228918A Method of preparing walnut polypeptide powder |
| 07/30/2008 | CN101228911A Tea for nourishing face and eliminating toxin |
| 07/30/2008 | CN100406570C Sgk and Nedd used as diagnostic and therapeutic targets |
| 07/30/2008 | CN100406467C Method for preparing total saponins from theroots of platycodon grandiflorum utilizing weak polarity macroreticular resin and its use |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406438C Preparation method of amorphous atorvastatin calcium |